Effects of Bupropion in Depression

NACompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

May 31, 2016

Study Completion Date

May 31, 2016

Conditions
Depression
Interventions
DRUG

Bupropion

Bupropion MR will be given open label to all participants in the depression group. Participants will receive 150mg od for one week. The dose will then be increased to 150mg bd for the following 5 weeks. Participants in the control group will recieve no drug. Note that the study is not assessing the safety or efficacy of buprion-- it is using bupropion to assess the neural effects of altering central dopaminergic function in depressed patients.

Trial Locations (1)

OX3 7JX

University of Oxford, Oxford

All Listed Sponsors
collaborator

Janssen Research & Development, LLC

INDUSTRY

lead

University of Oxford

OTHER

NCT02104128 - Effects of Bupropion in Depression | Biotech Hunter | Biotech Hunter